Background-The production of collagen is fundamental to atherosclerosis and critically dependent on posttranslational modification by prolyl 4-hydroxylase. Methods and Results-We report the cloning of a novel prolyl 4-hydroxylase catalytic (␣) subunit from human vascular smooth muscle cells. The peptide displayed conservation of critical residues for interacting with Fe 2ϩ and 2-oxoglutarate, essential cosubstrates for prolyl 4-hydroxylase activity. Furthermore, when the recombinant protein was expressed in cells, it associated with the ␤-subunit of prolyl 4-hydroxylase and could catalyze prolyl 4-hydroxylation of a collagen-like peptide. The tissue distribution was dissimilar from that of the 2 previously cloned ␣-subunits, suggesting a role beyond redundancy. Importantly, the novel gene was expressed in the fibrous cap of human carotid atherosclerotic lesions. Conclusions-The discovery of a novel prolyl 4-hydroxylase ␣-subunit, here termed the ␣(III)-subunit, suggests a new participant in collagen synthesis that, in view of the expression findings, may be relevant to atherosclerotic disease. 
T he production of type I collagen by smooth muscle cells (SMCs) is vital to vascular structure and function. Central to collagen elaboration is the winding of 3 pro-␣ collagen chains within the lumen of the endoplasmic reticulum to form a long triple-helical structure. This folding reaction depends critically on hydroxylation of proline residues in the pro-␣ collagen chains, a reaction catalyzed by the enzyme prolyl 4-hydroxylase. Prolyl 4-hydroxylases that modify collagens are tetramers comprised of 2 ␣-subunits, with provide the catalytic activity, and 2 ␤-subunits that are identical to protein disulfide isomerase (PDI). Ascorbate, Fe 2ϩ , 2-oxoglutarate, and O 2 are necessary cofactors for the reaction. 1 If the activity of prolyl 4-hydroxylase is suboptimal, the underhydroxylated procollagen chains misfold and are either secreted from the cell at a slow rate or targeted for intracellular degradation. 2 In the course of screening for genes expressed in maturing human SMCs, we identified an unknown cDNA fragment that displayed sequence homology to the ␣-subunit of prolyl 4-hydroxylase. In the present study, we report the discovery, cloning, and characterization of a new prolyl 4-hydroxylase catalytic subunit that is expressed in the fibrous cap of human atherosclerotic plaque.
Methods

Isolation of cDNA Clones
5Ј RACE (rapid amplification of cDNA ends) was performed by using an adaptor-ligated human placental library (marathon-ready cDNA, CLONTECH). Polymerase chain reaction (PCR) was performed by using the recommended 5Ј adapter primer and one of 2 gene-specific 3Ј primers (5Ј-ACTTGCCTCATCCTCTGTC-TTCC-3Ј or 5Ј-AAAGACCCACTGATCGAACC-3Ј). After subcloning, 15 RACE products were sequenced by using an ABI 377 prism DNA sequencer and aligned to obtain a composite nucleotide sequence. A combination of these data and the updated public sequence database allowed PCR primers to be designed to amplify the full-length gene. This was performed by using cDNA derived from HITB5 SMCs (cloned from the human internal thoracic artery), 3 5Ј-primer (5Ј-GACTGTCTGAGGGAAGTTCGC-3Ј), 3Ј-primer (5Ј-TCCTACTCTGACTTCCGTGGCTGG-3Ј), 1.5 mmol/L MgCl 2 , 5% DMSO, and high-fidelity platinum Taq polymerase (GIBCO). The 1885-bp product was subcloned into pCRII (Invitrogen) and analyzed by nucleotide sequencing.
Northern Blot Analysis
HITB5 SMCs, THP-1 monocytes (ATTC), and NT2/D1 cells (ATCC) differentiated to the neuroectoderm lineage by retinoic acid were lysed in Trizol (GIBCO), and total RNA was subjected to Northern blot analysis for pro-␣ 1 (I) collagen and GAPDH, as described. 4 The novel transcript was detected by using a 1664-bp cDNA probe derived from a RACE product (Clone 36). Prolyl 4-hydroxylase ␣(I)-and ␣(II)-subunit mRNA were detected by using full-length cDNA excised from plasmids kindly provided by J. Myllyharju (University of Oulu, Finland).
Immunoprecipitation of Expressed Epitope-Tagged cDNA Constructs
A fusion construct of cDNA encoding the cloned gene and a C-terminal myc tag was generated. Tagged cDNA constructs of full-length prolyl 4-hydroxylase ␣(I)-and ␣(II)-subunits were similarly generated. Human embryonic 293 cells were transfected with constructs by using calciumphosphate precipitation. Cellular PDI was then immunoprecipitated from transient transfectants by using a polyclonal antibody (StressGen) and protein A-agarose. Immunoprecipitates were washed extensively with RIPA buffer (1% igepal CA-630, 0.5% sodium deoxycholate, 0.1% SDS in PBS), resolved on a 7.5% polyacrylamide gel, and transferred to a nitrocellulose membrane. Membranes were incubated with monoclonal antibody to c-myc (Pharmingen), and bound primary antibody was detected by antimouse peroxidase-conjugated Fab fragments and chemiluminescence (Promega Corp).
Enzyme Activity Assay
To assess enzyme activity, 293 or HT1080 fibrosarcoma cells were cotransfected with cDNA encoding PDI and either prolyl 4-hydroxylase c-myc-tagged ␣(I)-or ␣(III)-subunits. Protein was immunoprecipitated in modified RIPA buffer, containing 1% NP-40, 0.25% deoxycholate, and no SDS, using anti-c-myc antibody and capture ligand, which was then bound reversibly to a column resin. The washed immune complex was then released in soluble form in elution buffer (Capture and Release, Upstate). Prolyl 4-hydroxylation of the collagen-like peptide (Pro-Pro-Gly) 5 was then assayed, based on the hydroxylation-coupled decarboxylation of 2-oxo[1-14 C glutarate] (Perkin Elmer). 5
In Situ Hybridization
Human carotid endarterectomy samples were fixed in 4% paraformaldehyde overnight and frozen in OCT. Nonradioactive RNA in situ hybridization was performed on 6-m sections by using a digoxigenin-labeled antisense riboprobe transcribed from a 488-bp fragment of Clone 36. Incubation of artery tissue with a sense probe transcribed from the same template, as well as incubation of brain tissue with the antisense probe, confirmed the absence of nonspecific signals. Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI, 0.5 g/mL) (Sigma).
Results
While screening for differentially expressed transcripts in maturing HITB5 SMCs, we identified a 728-bp reverse transcription (RT)-PCR product that was noteworthy because the predicted amino acid sequence of the first 133 nucleotides displayed homology with the human prolyl 4-hydroxylase ␣(I)-subunit. 6 The strategy used for cloning the gene, as well as a representation of some of the cDNA clones isolated, is illustrated in Figure 1A . RT-PCR using HITB5 SMC RNA was performed as a final step, generating a 1885-bp cDNA clone that consisted of 33 bp of 5ЈUTR, 1632 bp of coding sequence, and 220 bp of 3ЈUTR. Sequence alignment with the 2 currently known human prolyl 4-hydroxlase ␣-subunits, ␣(I) and ␣(II), showed homology throughout the length of the novel gene ( Figure 1B ) which, based on subsequent enzyme analysis, we termed the prolyl 4-hydroxylase ␣(III)-subunit (sequence deposited in GenBank, accession number AY327887). The Table compares details of the 3 genes showing similarities in protein size; the presence of an N-terminal signal peptide, deduced using the computational parameters of von Heijne 7 ; and the absence of an ER retention signal, which for collagen prolyl 4-hydroxylases is afforded by the ␤-subunit. 1 The region of least homology with the ␣(I)-and ␣(II)-subunits occurs at a variable interdomain region, 8 whereas close homology exists in functionally critical regions. There are 5 conserved cysteine residues, 4 of which have been shown in the ␣(I)-subunit to form intrachain disulfide bonds essential to maintaining the structure required for tetramer assembly. 1 As well, homology is greatest at the catalytically important C-terminus. Within this terminus, there is conservation of 5 key residues essential for cosubstrate binding: 3 residues critical for binding Fe 2ϩ (which in the ␣(III)-subunit correspond to His-421, Asp-423, and His-491), a lysine required to bind the C-5 carboxyl group of 2-oxoglutarate (Lys-501), and a histidine involved in binding the C-1 carboxyl group of 2-oxoglutarate to Fe 2ϩ and the decarboxylation of this cosubstrate (His-509). 1 Collectively, these data strongly suggest that the cloned gene is a prolyl 4-hydroxylase catalytic subunit. The sequence data also place it in the family of prolyl 4-hydroxylases that act on collagen rather than on hypoxia-inducible factor. 9 This was further supported by expression data. Transcripts for the prolyl 4-hydroxylase ␣(III) subunit were detected in type I collagen-producing SMCs but not in 2 different cell lines that did not express type I collagen (Figure 2A) .
To constitute mammalian collagen prolyl 4-hydroxylase, an ␣-subunit must associate with the ␤-subunit, PDI. To determined if the ␣(III)-subunit associated with PDI, a c-myc-tagged ␣(III)-construct was expressed in 293 cells from which PDI was immunoprecipitated. As shown in Figure 2B , the ␣(III)-subunit coimmunoprecipitated with PDI, as did the epitope-tagged ␣(I)-and ␣(II)-subunits of prolyl 4-hydroxylase, whereas there was no immunoreactive band in sham-transfected cells. Reversing the antibodies used for immunoprecipitation and immunoblotting gave similar results (data not shown).
To test for enzymatic activity of the ␣(III)-subunit-containing protein, c-myc-tagged ␣(III)-subunit was coexpressed with PDI in HT1080 fibrosarcoma cells. Protein was immunoprecipitated by using anti-c-myc antibody, released from binding resin in a soluble state, and assayed for prolyl 4-hydroxylation of a collagen-like peptide. As shown in Figure 2C , the recovered protein displayed enzymatic activity, similar to that of the ␣(I)-subunit-containing protein.
Prolyl 4-hydroxylase ␣(III)-subunit transcripts were found to be expressed in human placenta, liver, and skeletal muscle ( Figure 2D ). We also compared the expression profile of the ␣(III)-subunit in maturing HITB5 SMCs with that of the ␣(I)-and ␣(II)-subunits. Interestingly, all 3 transcripts were expressed in HITB5 SMCs, but only the ␣(II)-subunit mRNA increased as SMCs matured ( Figure 2E ).
The fidelity of collagen production is central to atheromatous disease. As illustrated in Figure 2F through 2H, we identified expression of the ␣(III)-subunit, by in situ hybridization, in atherosclerotic carotid artery samples harvested from 5 of 10 patients. The strongest and most prevalent staining was in SMC-like cells within the fibrous cap of lipid-rich lesions. Cells within the necrotic lipid core did not express the gene. As well, the media of nonatherosclerotic artery samples (internal thoracic artery, nϭ2) showed little if any expression of the ␣(III)-subunit transcript.
Discussion
Until recently, the collagen prolyl 4-hydroxylase was believed to be an isolated enzyme that was not part of a family. An isoform of the catalytic subunit, designated ␣(II), however, was recently cloned from humans. 10 Because the ␤-subunit (PDI) is invariant, it was established that the ␣-subunit functionally defines the collagen prolyl 4-hydroxylase enzyme. We have discovered, cloned, and characterized a gene encoding a new prolyl 4-hydroxylase ␣-subunit, termed the ␣(III)-subunit. This gene is expressed by SMCs and found, among other tissues, in the fibrous cap of atherosclerotic human carotid arteries.
Key features of the ␣(III)-subunit include (1) sequence similarity with the ␣(I)-and ␣(II)-subunits of prolyl 4-hydroxylase, (2) conservation of cysteines required in prolyl hydroxylases for tertiary structure and enzymatic function, (3) conservation of residues necessary for binding Fe 2ϩ and 2-oxoglutarate, (4) specific expression in collagenproducing cells, (5) intracellular association with the ␤-subunit of prolyl-4-hydroxylase, and (6) collagen prolyl 4-hydroxylase activity when expressed with the ␤-subunit.
The reason for multiple prolyl 4-hydroxylase ␣-subunits is speculative. One possibility is the presence of "back-up" systems, given that the loss of collagen proline hydroxylation would be lethal. However, the expression profiles for the ␣(I)-, ␣(II)-, and ␣(III)-transcripts are dissimilar. The tissue expression of the ␣(III)-subunit is more restricted than that of the ␣(I)-subunit and, unlike the ␣(II)-subunit, excludes the lung. 10, 11 Complete redundancy of roles therefore seems unlikely. In support of this, although human SMCs expressed all 3 transcripts, only the ␣(II)-subunit was upregulated in relatively well-differentiated SMCs, a relationship with dif- Figure 1 . A, Cloning strategy. The original cDNA fragment (clone 31-1) contained 133 bp of putative coding sequence, 3ЈUTR, and a poly A tail. 5ЈRACE reactions generated clones 36, 224, and 371, but none of 15 clones sequenced extended to the putative translational start site. GenBank and clone sequences were used to design primers P3 and P4, from which the fulllength coding sequence was generated by RT-PCR from RNA harvested from HITB5 SMCs. B, Peptide sequence aligned with that of prolyl 4-hydroxylase ␣(I)-and ␣(II)-subunits. A 19-amino-acid signal peptide sequence also exists at the N-terminus (MGPGARLAALLAVLAL-GTG). Ⅲ denotes sequence identity; u, sequence similarity. ⅷ denotes conserved cysteine residues involved in maintaining structure of the ␣(I)-subunit. *Denotes conserved residues critical for cosubstrate binding. ferentiation that has also been noted with osteoblasts. 11 The possibility of differential participation of prolyl 4-hydroxylase isoforms in vascular restructuring therefore warrants study. In addition, because the ␣(III)-subunit was expressed in other tissues, a broader role is also likely. In summary, discovery of the prolyl 4-hydroxylase ␣(III)-subunit suggests a new molecular participant in collagen production that may be relevant to development or repair of a number of tissues, including the atheromatous artery wall. 
Comparison of Prolyl 4-Hydroxylase ␣-Subunits
